6505--Clobetasol Cream and Ointment (VA-25-00041429)

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest solicitation from .

Solicitation number
36E79725R0040
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs (VA) National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0040 for Clobetasol Propionate 0.05% Cream and Ointment, which will serve multiple federal agencies including VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The procurement is divided into two groups: Group I for Cream and Group II for Ointment, with each group containing four different package sizes ranging from 15 to 60 grams per tube. Offerors must provide products with unique National Drug Code (NDC) numbers, and their label must be the only one on the product, with specific packaging requirements including matching barcodes and secure tube placement. The solicitation will be electronically issued on May 22, 2025, with a response deadline of June 5, 2025, and potential questions can be emailed to Raymond.Roldan@va.gov. The VA will award one contract for each group to the responsible offeror capable of providing an uninterrupted supply of the contracted items.

The procurement is an unrestricted contract with no specific set-aside designations, allowing all responsible sources to submit offers. The contract will have an initial one-year term with four additional one-year option periods, to be distributed through VA and DoD Pharmaceutical Prime Vendor Programs. Total estimated annual usage varies by package size, with Group I Cream ranging from 19,351 to 130,598 tubes and Group II Ointment ranging from 25,173 to 123,024 tubes. If a single offeror is awarded both groups, a single contract will be issued covering all line items. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, and no paper copies of the solicitation will be available, with all documents to be accessed electronically through SAM.gov. Interested vendors are advised to continuously monitor the SAM.gov website for any amendments or changes to the solicitation.

Notice text

PRE-SOLICITATION NOTICE:Â The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0040 for an unrestricted procurement for Clobetasol Propionate 0.05% Cream and Ointment, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

VA will award one contract for each Group - Group I and Group II - to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items (1, 2, 3, and 4). If a single offeror is awarded both groups, a single contract award including all line items/both groups will be issued. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.

Offerors must state the exact name (name that appears on label) and strength by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. The NDC numbers must be readable on the box and tube. The barcode on box must match the barcode on the tube. The tube must be in the box with no flap (i.e. punch hole hanger). Additionally, the box must be sealed in such a way where the tube cannot slip out when tipped upside down or sideways. Items are identified in the Schedule of Supplies.

Solicitation # 36E79725R0040 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 22, 2025, with a tentative closing date of June 5, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Ray Roldan. Questions can be e-mailed to Raymond.Roldan@va.gov.

The estimated annual requirements are as follows:

Requirements DescriptionÂ

Group I Clobetasol Propionate 0.05% Topical Cream

Item

Description

Package Size (Grams per Tube)

Total Estimated Annual Usage (Tubes)

1

Clobetasol Propionate 0.05% Cream, Topical

15

64,807

2

Clobetasol Propionate 0.05% Cream, Topical

30

130,598

3

Clobetasol Propionate 0.05% Cream, Topical

45

19,351

4

Clobetasol Propionate 0.05% Cream, Topical

60

63,640

Group II Clobetasol Propionate 0.05% Topical Ointment

Item

Description

Package Size (Grams per Tube)

Total Estimated Annual Usage (Tubes)

1

Clobetasol Propionate 0.05% Ointment, Topical

15

73,820

2

Clobetasol Propionate 0.05% Ointment, Topical

30

123,024

3

Clobetasol Propionate 0.05% Ointment, Topical

45

25,173

4

Clobetasol Propionate 0.05% Ointment, Topical

60

70,291

Files

File Type Posted
36E79725R0040_1.docx DOCX document

Notice history

Notice Type Posted
6505--Clobetasol Cream and Ointment Encube Ethicals, Inc. Base Ordering Period 11/17/2025 - 11/16/2026 Award Award Notice
6505--Clobetasol Cream and Ointment (VA-25-00041429) Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Ramipril Capsules RFP NAICS 325412 National Acquisition Center No set-aside
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside
6505--Latanoprost Ophthalmic Solution (VA-27-00006027) NAICS 325412 National Acquisition Center No set-aside
Lidocaine 5% patches-request for information Kansas 66048, United States · NAICS 325412 Veterans Integrated Service Network 15 No set-aside
6505--FY27 Lenalidomide BPA Department of Veterans Affairs Participating VA Medical Centers · NAICS 325412 Veterans Integrated Service Network 22 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors